🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if the addition of apalutamide to...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2015-11-27
Trial ID
NCT02489318
Treatments Being Tested
This phase III trial studies whether adding apalutamide to the usual treatm...
Status
Active Not Recruiting
Location
Cancer Center at Saint Joseph's
Start Date
2020-04-16
Trial ID
NCT04134260
This phase II trial studies how well apalutamide and gonadotropin-releasing...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2017-10-13
Trial ID
NCT03279250
This phase II trial studies how well the combination of apalutamide, abirat...
Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2020-05-11
Trial ID
NCT04267887
The purpose of this study is to determine if apalutamide plus gonadotropin ...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2015-11-19
Trial ID
NCT02531516
The purpose of this study is to investigate potential drug-drug interaction...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2014-07-09
Trial ID
NCT02123758
Treatments Being Tested
This phase II trial studies how well apalutamide, abiraterone acetate, pred...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2017-03-09
Trial ID
NCT02849990
Treatments Being Tested
This phase II trial studies how well apalutamide and abiraterone acetate wo...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2018-03-06
Trial ID
NCT03360721
Treatments Being Tested
The purpose of this study is to evaluate the effects of repeat dosing of JN...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2016-02-12
Trial ID
NCT02592317
Treatments Being Tested
This phase II trial tests how well golimumab and apalutamide work in treati...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2024-05-23
Trial ID
NCT05960578